|
Index of reports
> Cases with Anaemia (322)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include anaemia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 322 Next >>
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Renal Impairment, Anaemia, Pancreatitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-04-27
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-05-24
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-05-25
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-05-17
Other drugs received by patient: Antebate; Prednisolone; Dexaltin; Ubiron; Aspara CA; Loxonin; Onealfa; Diovan; Berizym (Lysozyme Chloride); Mirobect; Amlodipine; Isoleucine (+) Leucine (+) Valine; Lansoprazole; Mucosta
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Anaemia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.8 microgram per kilogram, qw
Start date: 2012-05-08
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-04-24
PEG-Intron
Dosage: 1.0 microgram per kilogram, qw
Start date: 2012-05-01
End date: 2012-05-01
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-18
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-07-12
Other drugs received by patient: Claritin; Ferotym; Livalo; Epadel S
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: White Blood Cell Count Decreased, Renal Impairment, Anaemia, Platelet Count Decreased, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 mcg /kg/week
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-04-25
PEG-Intron
Dosage: 1.0 mcg /kg/week
Start date: 2012-06-26
PEG-Intron
Dosage: 1.0 mcg /kg/week
Start date: 2012-04-26
End date: 2012-06-06
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-06-06
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-26
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-06-07
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-06-26
End date: 2012-07-24
Other drugs received by patient: Motilium; Lorfenamin; Motilium; L Cartin; Rikkunshi-TO; Epadel
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Anaemia, Blood Uric Acid Increased, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 30 microgram per kilogram, qw
Start date: 2012-07-05
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-06-21
PEG-Intron
Dosage: 50 microgram per kilogram, qw
Start date: 2012-07-12
PEG-Intron
Dosage: 70 microgram per kilogram, qw
Start date: 2012-07-19
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-06-27
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-07-05
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-06-27
Other drugs received by patient: Theo-DUR; Lendormin; Mucodyne
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Anaemia, Rash, Haemolytic Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-03-16
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-03-15
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-04-24
End date: 2012-05-21
Ribavirin
Dosage: 500 mg, qd
Administration route: Oral
Start date: 2012-05-22
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-03-21
End date: 2012-04-03
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-02-27
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-02-28
End date: 2012-03-17
Ribavirin
Dosage: 300 mg, qd
Administration route: Oral
Start date: 2012-04-04
End date: 2012-04-23
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-03-16
Other drugs received by patient: Coniel; Famotidine; Allopurinol; Celestamine (Betamethasone (+) Dexchlorpheniramine Maleate (+) Fluphen; Isosorbide Dinitrate
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: White Blood Cell Count Decreased, Contusion, Anaemia, Fall, Loss of Consciousness, Haemoglobin Decreased, Anxiety, Dysgeusia, Urine Uric Acid Increased, Disturbance in Attention, Injury, Feeling Abnormal, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-03
Rebetol
Dosage: unk unk, qam
Indication: Hepatitis C
Start date: 2012-03-03
Rebetol
Dosage: unk unk, qpm
Rebetol
Dosage: unk unk, qam
Rebetol
Dosage: unk unk, qpm
Start date: 2012-03-03
Rebetol
Dosage: unk unk, qpm
Rebetol
Dosage: unk unk, qam
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-31
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Pancreatitis Acute, Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-11
End date: 2012-06-15
Rebetol
Dosage: 800 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-11
End date: 2012-06-20
Telaprevir
Dosage: 2250 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-11
End date: 2012-06-20
Other drugs received by patient: Talion (Bepotastine Besylate); Feburic; Famostagine D; NEO-Minophagen C; Urdeston; Trebianom; Sitagliptin Phosphate
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Anaemia
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-04
PEG-Intron
Dosage: 1.5 ?g/kg, qw
Indication: Hepatitis C
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-02-08
Ribavirin
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
End date: 2012-02-07
Other drugs received by patient: Lorfenamin; Livalo; Epadel S; Claritin Reditabs; Sodium Ferrous Citrate
Possible PEG-Intron side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: female
Reactions: Dehydration, Anaemia, Lower Respiratory Tract Inflammation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-02-15
Ribavirin
Dosage: unk
Indication: Hepatitis C
Start date: 2012-02-15
VX-950
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-15
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-25
Patient:
Reactions: Anaemia, Rash
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-12
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-07-02
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-07-01
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-12
Other drugs received by patient: Claritin Reditabs Tablets 10 MG; Diltiazem Hydrochloride; Livalo; Epadel S; Ferotym
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-25
Patient:
Reactions: Gastrointestinal Haemorrhage, Anaemia, Haematemesis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2011-11-02
End date: 2012-06-27
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-02
End date: 2012-05-28
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-05-29
End date: 2012-06-30
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Start date: 2012-05-14
End date: 2012-05-22
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-05-23
End date: 2012-06-30
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-09
End date: 2012-05-11
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Pancreatitis Acute, Amylase Increased, Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-02-29
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-03-01
End date: 2012-03-20
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-03-27
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-01-31
End date: 2012-03-20
Rebetol
Dosage: 600 mg, once
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-01-30
Telavic
Dosage: 2250 mg, once
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-02-29
Telavic
Dosage: 1500 mg, once
Administration route: Oral
Start date: 2012-03-01
End date: 2012-03-20
Telavic
Dosage: unk
Other drugs received by patient: Glufast; Glufast; Tamiflu; Zantac; Primperan TAB; Tamiflu; Acetaminophen; Zantac
Possible PEG-Intron side effects in 67 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24
Patient: 67 year old female
Reactions: Nausea, Anaemia, Platelet Count Decreased, Blood Creatinine Increased, Hyperuricaemia, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.94 a?g/kg, unk
Start date: 2012-04-06
End date: 2012-04-26
PEG-Intron
Dosage: 1.3 a?g/kg, unk
Start date: 2012-03-30
PEG-Intron
Dosage: 1.13 a?g/kg, unk
Start date: 2012-04-27
End date: 2012-05-10
PEG-Intron
Dosage: 1.3 a?g/kg, unk
Start date: 2012-05-11
End date: 2012-08-02
PEG-Intron
Dosage: 1.5 a?g/kg, unk
Indication: Hepatitis C
Start date: 2012-02-17
End date: 2012-03-29
PEG-Intron
Start date: 2012-05-11
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-03-16
End date: 2012-04-19
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-02-24
End date: 2012-03-15
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-04-20
End date: 2012-08-02
Ribavirin
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-17
End date: 2012-02-23
VX-950
Dosage: 750 mg, qd
Administration route: Oral
Start date: 2012-03-23
End date: 2012-04-13
VX-950
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-02-24
End date: 2012-03-22
VX-950
Dosage: 2250 mg, qd
Indication: Hepatitis C
Start date: 2012-02-17
End date: 2012-02-23
Other drugs received by patient: Diovan; Urso / 00465701 /; Innolet; Amlodipine
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Anaemia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-13
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-13
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-13
Other drugs received by patient: Ferotym; Epadel S; Livalo; Claritin Reditabs
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Anaemia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-06
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-20
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-06
End date: 2012-06-19
Telavic
Dosage: 1500 milligrams, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-06
Other drugs received by patient: Lexotan; Norvasc; Mucosta; Epadel S; Ferotym; Depas; Maglax (Magnesium Oxide); Claritin Reditabs Tablets 10 MG; Livalo
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Renal Disorder, Anaemia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-04-28
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-28
End date: 2012-05-10
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-05-11
End date: 2012-05-31
Rebetol
Dosage: 200 mg, qd
Start date: 2012-06-01
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-28
End date: 2012-05-03
Telavic
Dosage: 1000 mg, qd
Administration route: Oral
Start date: 2012-06-01
End date: 2012-06-21
Telavic
Dosage: 1500 mg, qd
Start date: 2012-06-22
End date: 2012-07-20
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-05-04
End date: 2012-05-31
Other drugs received by patient: Ferotym; Livalo; Epadel S; Claritin Reditabs
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient:
Reactions: Abdominal Pain, White Blood Cell Count Decreased, Confusional State, Tinnitus, Pain, Chills, Anaemia, Hot Flush, Fatigue, Diarrhoea, Depression, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 ?g, qw
Indication: Hepatitis C
Start date: 2012-04-27
Ribasphere
Dosage: unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-27
Other drugs received by patient: Prograf
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Anaemia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, unk
Indication: Hepatitis C
Start date: 2012-06-02
Rebetol
Dosage: stop interval: 2 day
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-02
End date: 2012-06-14
Rebetol
Dosage: stop interval: 2 day
Administration route: Oral
Start date: 2012-06-15
Telavic
Dosage: 1000 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-02
Other drugs received by patient: Claritin Reditabs; Omeprazole; Nifedipine; Ferotym; Allopurinol; Benecid; Livalo; Epadel S; Micardis; Onealfa
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-24
Patient:
Reactions: Anaemia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Indication: Hepatitis C
Start date: 2012-05-10
End date: 2012-08-02
Rebetol
Dosage: 1000 mg, qd
Administration route: Oral
Start date: 2012-07-06
End date: 2012-07-22
Rebetol
Dosage: 600 mg, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-10
End date: 2012-08-02
Rebetol
Dosage: 800 mg, qd
Start date: 2012-07-23
End date: 2012-08-02
Rebetol
Dosage: 600 mg, qd
Start date: 2012-08-14
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-07
End date: 2012-08-06
Other drugs received by patient: Truvada; Metformin Hydrochloride; Losartan Potassium; Procrit; Ondansetron; Fenofibrate; Isentress; Vitamins (Unspecified); Neupogen
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-08-24
Patient:
Reactions: Weight Decreased, Tongue Disorder, Anaemia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Indication: Hepatitis C
Start date: 2012-04-24
End date: 2012-01-01
PEG-Intron
Dosage: 120 microgram, qw
Start date: 2012-01-01
Rebetol
Dosage: 2x 200 mg in the morning and 200 mg in the evening
Start date: 2012-08-09
Rebetol
Dosage: unk unk, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-24
End date: 2012-01-01
Rebetol
Dosage: 600 mg in the morning and 400 mg in the evening
Administration route: Oral
Start date: 2012-01-01
End date: 2012-08-08
Other drugs received by patient: Vasexten; Januvia; Valsartan and Hydrochlorothiazide; Glucophage; Nobiten
Possible PEG-Intron side effects in
Reported by a physician from Argentina on 2012-08-24
Patient:
Reactions: Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Boceprevir
Dosage: 2400 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-07-15
End date: 2011-01-13
PEG-Intron
Dosage: 150 units
Indication: Hepatitis C
Start date: 2010-07-15
End date: 2011-01-06
Peginterferon Alfa-2B
Dosage: 2400 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-07-15
End date: 2011-01-13
Placebo
Dosage: 2400 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-07-15
End date: 2011-01-13
Ribavirin
Dosage: 2400 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-07-15
End date: 2011-01-13
Ribavirin
Dosage: 2400 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-07-15
End date: 2011-01-12
Simvastatin
Dosage: 2400 mg, unk
Administration route: Oral
Start date: 2010-07-15
End date: 2011-01-13
Simvastatin
Dosage: 2400 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-07-15
End date: 2011-01-13
Simvastatin
Dosage: 2400 mg, unk
Administration route: Oral
Start date: 2010-07-15
End date: 2011-01-13
Simvastatin
Dosage: 2400 mg, unk
Administration route: Oral
Start date: 2010-07-15
End date: 2011-01-13
Simvastatin
Dosage: 2400 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-07-15
End date: 2011-01-13
Simvastatin
Dosage: 2400 mg, unk
Administration route: Oral
Start date: 2010-07-15
End date: 2011-01-13
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-24
Patient:
Reactions: Anaemia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 microgram, qw
Indication: Hepatitis C
Start date: 2008-02-07
End date: 2008-06-02
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2008-02-07
End date: 2008-02-28
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2008-02-29
End date: 2008-03-06
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2008-03-07
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: Anaemia, Hyperuricaemia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-04-24
End date: 2012-05-21
PEG-Intron
Dosage: 1.2 microgram per kilogram, qw
Start date: 2012-05-22
End date: 2012-07-16
PEG-Intron
Dosage: 0.6 microgram per kilogram, qw
Start date: 2012-07-17
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-24
End date: 2012-05-01
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-05-04
End date: 2012-05-14
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-05-02
End date: 2012-05-03
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-05-15
Telaprevir
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-05-15
End date: 2012-07-02
Telaprevir
Dosage: 750 mg, qd
Administration route: Oral
Start date: 2012-07-03
End date: 2012-07-16
Telaprevir
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-24
End date: 2012-05-14
Other drugs received by patient: Glyburide; Actos
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: Anaemia, Ascites
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-07
End date: 2012-07-12
PEG-Intron
Dosage: 50 microgram, qw
Start date: 2012-07-12
End date: 2012-07-18
Rebetol
Dosage: 600 mg, qd (cumulative dose: 8400 mg)
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-07
Rebetol
Dosage: 400 mg, qd (cumulative dose: 8400 mg)
Administration route: Oral
Start date: 2012-07-05
End date: 2012-07-12
Rebetol
Dosage: 200 mg, qd (cumulative dose: 8400 mg)
Administration route: Oral
Start date: 2012-07-12
End date: 2012-07-17
Telavic
Dosage: 1500 mg, qd (cumulative dose: 29250 mg)
Administration route: Oral
Start date: 2012-06-18
End date: 2012-07-17
Telavic
Dosage: 2250 mg, qd (cumulative dose: 29250 mg)
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-07
End date: 2012-06-17
Other drugs received by patient: Motilium; Salagen; Allopurinol; Lansoprazole; Amlodipine; Candesartan Cilexetil
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: Renal Disorder, Anaemia
Drug(s) suspected as cause:
Investigational Drug (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-01-16
Investigational Drug (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-10
End date: 2012-01-13
PEG-Intron
Dosage: 1.0mcg/kg/week
Start date: 2012-02-06
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-01-10
End date: 2012-01-30
PEG-Intron
Dosage: 1.2mcg/kg/week
PEG-Intron
Dosage: 1.0mcg/kg/week
End date: 2012-06-18
Peginterferon Alfa-2B
Dosage: 1.2 ?g/kg, qw
Peginterferon Alfa-2B
Dosage: 1.5 ?g/kg, qw
Indication: Hepatitis C
Start date: 2012-01-10
End date: 2012-01-30
Peginterferon Alfa-2B
Dosage: 1.0 ?g/kg, qw
Start date: 2012-02-06
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-03-13
Rebetol
Dosage: 600 mg, once
Administration route: Oral
Start date: 2012-05-21
End date: 2012-06-18
Rebetol
Dosage: 600 mg, once
Administration route: Oral
Start date: 2012-03-13
End date: 2012-05-06
Rebetol
Dosage: 800 mg, once
Administration route: Oral
Start date: 2012-05-07
End date: 2012-05-20
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-10
End date: 2012-02-12
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-02-13
End date: 2012-03-12
Telavic
Dosage: 2250 mg, once
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-10
End date: 2012-01-13
Telavic
Dosage: 1500 mg, once
Administration route: Oral
Start date: 2012-01-16
Other drugs received by patient: Epadel; Claritin Reditabs; Sodium Ferrous Citrate; Alenapion; Ferotym; Claritin Reditabs; Singulair; Singulair; Livalo; Livalo; Epadel S; Livalo; Epinastine Hydrochloride
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient:
Reactions: Weight Decreased, non-Consummation, Fatigue, Malaise, RED Blood Cell Count Decreased, White Blood Cell Count Decreased, Vein Disorder, Vomiting, Nausea, Anaemia, Hypoaesthesia, Mental Impairment, Diarrhoea, Alopecia, Feeling Abnormal, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-09-08
End date: 2012-08-09
Ribavirin
Dosage: unk unk, unknown
Start date: 2011-09-08
End date: 2012-08-09
Other drugs received by patient: Telaprevir
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Brazil on 2012-08-23
Patient:
Reactions: White Blood Cell Count Decreased, Oedema Peripheral, Anaemia, Abdominal Distension, Pyrexia, Asthenia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk, qw
Indication: Hepatitis C
Start date: 2012-01-02
End date: 2012-07-25
Ribavirin
Dosage: unk, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-02
End date: 2012-07-25
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-23
Patient:
Reactions: Anaemia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-26
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-06-14
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-26
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-26
Other drugs received by patient: Claritin Reditabs Tablets 10 MG; Livalo; Epadel S; Ferotym; Amlodipine Towa
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: Weight Decreased, Renal Function Test Abnormal, Alopecia, Haemorrhoids, Anaemia, Urticaria, Vision Blurred, Headache
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 microgram, qw
Indication: Hepatitis C
Start date: 2010-10-01
PEG-Intron
Dosage: 120 unk, unk
Start date: 2012-06-20
End date: 2012-08-16
Ribasphere
Dosage: unk
Indication: Hepatitis C
Telaprevir
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-13
Possible PEG-Intron side effects in
Reported by a individual with unspecified qualification from United States on 2012-08-23
Patient:
Reactions: Anal Fistula, Anorectal Discomfort, Haemorrhoids, Anaemia, Adverse Event
Adverse event resulted in: disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 microgram, qw
Start date: 2012-05-25
Ribasphere
Dosage: 200mg in am 400mg pm
Other drugs received by patient: Procrit; Telaprevir
Page 1 Next >>
|
